Process for the manufacture of thrombin inhibitors
US5422249A · kind A · utility
6Cited by
4References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 15, 1993 |
| Grant date | Jun 6, 1995 |
| Priority date | — |
| Expiry date | Sep 15, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/10
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to DNA sequences that code for the amino acid sequence of the thrombin inhibitor hirudin, hybrid vectors containing such DNA sequences, host cells transformed with such hybrid vectors, novel polypeptides with thrombin-inhibiting activity produced from such transformed host cells, processes for the manufacture of these DNA sequences, hybrid vectors and transformed host cells, and processes for the manufacture of these thrombin-inhibitors using the transformed host cells. The hirudin compounds that can be produced according to the invention have valuable pharmacological properties.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.